These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1426 related items for PubMed ID: 19386274

  • 1. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y, Nishikawa M, Takakura Y.
    Adv Drug Deliv Rev; 2009 Jul 25; 61(9):760-6. PubMed ID: 19386274
    [Abstract] [Full Text] [Related]

  • 2. Strategies for short hairpin RNA delivery in cancer gene therapy.
    Wang SL, Yao HH, Qin ZH.
    Expert Opin Biol Ther; 2009 Nov 25; 9(11):1357-68. PubMed ID: 19761417
    [Abstract] [Full Text] [Related]

  • 3. HIV-1-specific RNA interference.
    Boden D, Pusch O, Ramratnam B.
    Curr Opin Mol Ther; 2004 Aug 25; 6(4):373-80. PubMed ID: 15468596
    [Abstract] [Full Text] [Related]

  • 4. RNA interference (RNAi) in hematology.
    Scherr M, Steinmann D, Eder M.
    Ann Hematol; 2004 Jan 25; 83(1):1-8. PubMed ID: 14574462
    [Abstract] [Full Text] [Related]

  • 5. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A.
    J Biotechnol; 2006 Jun 25; 124(1):12-25. PubMed ID: 16413079
    [Abstract] [Full Text] [Related]

  • 6. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y, Li Z, Li L, Li J, Liu X, Li W.
    Int J Mol Med; 2007 Apr 25; 19(4):705-11. PubMed ID: 17334648
    [Abstract] [Full Text] [Related]

  • 7. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S, Benter I.
    Adv Drug Deliv Rev; 2007 Mar 30; 59(2-3):164-82. PubMed ID: 17481774
    [Abstract] [Full Text] [Related]

  • 8. Stable suppression of gene expression in murine embryonic stem cells by RNAi directed from DNA vector-based short hairpin RNA.
    Tang FC, Meng GL, Yang HB, Li CJ, Shi Y, Ding MX, Shang KG, Zhang B, Xue YF.
    Stem Cells; 2004 Mar 30; 22(1):93-9. PubMed ID: 14688395
    [Abstract] [Full Text] [Related]

  • 9. Short hairpin RNA and retroviral vector-mediated silencing of p53 in mammalian cells.
    Liu XD, Ma SM, Liu Y, Liu SZ, Sehon A.
    Biochem Biophys Res Commun; 2004 Nov 26; 324(4):1173-8. PubMed ID: 15504337
    [Abstract] [Full Text] [Related]

  • 10. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
    Wu RH, Cheng TL, Lo SR, Hsu HC, Hung CF, Teng CF, Wu MP, Tsai WH, Chang WT.
    J Gene Med; 2007 Jul 26; 9(7):620-34. PubMed ID: 17486668
    [Abstract] [Full Text] [Related]

  • 11. RNA interference and its current application in mammals.
    Shen WG.
    Chin Med J (Engl); 2004 Jul 26; 117(7):1084-91. PubMed ID: 15265387
    [Abstract] [Full Text] [Related]

  • 12. [RNA interference directed by small hairpin RNA expressed in COS-7 cells].
    Tang FC, Yang HB, Meng GL, Li CJ, Shang KG, Zhang B, Xue YF.
    Yi Chuan Xue Bao; 2003 Apr 26; 30(4):295-300. PubMed ID: 12812050
    [Abstract] [Full Text] [Related]

  • 13. Vector-based in vivo RNA interference: dose- and time-dependent suppression of transgene expression.
    Kobayashi N, Matsui Y, Kawase A, Hirata K, Miyagishi M, Taira K, Nishikawa M, Takakura Y.
    J Pharmacol Exp Ther; 2004 Feb 26; 308(2):688-93. PubMed ID: 14610223
    [Abstract] [Full Text] [Related]

  • 14. The RNA silencing technology applied by lentiviral vectors in oncology.
    Sumimoto H, Kawakami Y.
    Methods Mol Biol; 2010 Feb 26; 614():187-99. PubMed ID: 20225045
    [Abstract] [Full Text] [Related]

  • 15. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
    Golzio M, Mazzolini L, Ledoux A, Paganin A, Izard M, Hellaudais L, Bieth A, Pillaire MJ, Cazaux C, Hoffmann JS, Couderc B, Teissié J.
    Gene Ther; 2007 May 26; 14(9):752-9. PubMed ID: 17344906
    [Abstract] [Full Text] [Related]

  • 16. Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice: quantitative analysis using melanoma cells expressing firefly and sea pansy luciferases.
    Takahashi Y, Nishikawa M, Kobayashi N, Takakura Y.
    J Control Release; 2005 Jul 20; 105(3):332-43. PubMed ID: 15936841
    [Abstract] [Full Text] [Related]

  • 17. Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells.
    Hoelters J, Ciccarella M, Drechsel M, Geissler C, Gülkan H, Böcker W, Schieker M, Jochum M, Neth P.
    J Gene Med; 2005 Jun 20; 7(6):718-28. PubMed ID: 15712343
    [Abstract] [Full Text] [Related]

  • 18. Vectors for RNA interference.
    Wadhwa R, Kaul SC, Miyagishi M, Taira K.
    Curr Opin Mol Ther; 2004 Aug 20; 6(4):367-72. PubMed ID: 15468595
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of Dicer enhances RNAi-mediated gene silencing by short-hairpin RNAs (shRNAs) in human cells.
    Mikuma T, Kawasaki H, Yamamoto Y, Taira K.
    Nucleic Acids Symp Ser (Oxf); 2004 Aug 20; (48):191-2. PubMed ID: 17150543
    [Abstract] [Full Text] [Related]

  • 20. Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells.
    Arthanari Y, Pluen A, Rajendran R, Aojula H, Demonacos C.
    J Control Release; 2010 Aug 03; 145(3):272-80. PubMed ID: 20403398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.